We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+4.68%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$7.17B
AUM Growth
+$156M
(+2.2%)
Cap. Flow
-$121M
Cap. Flow
% of AUM
-1.68%
Top 10 Holdings %
Top 10 Hldgs %
30.59%
Holding
2,144
New
214
Increased
421
Reduced
861
Closed
501
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lamb Weston
LW
|
+$73.2M |
| 2 |
Deere & Co
DE
|
+$67M |
| 3 |
JPMorgan Chase
JPM
|
+$40.3M |
| 4 |
Meta Platforms (Facebook)
META
|
+$36.9M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$33.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$147M |
| 2 |
Synchrony
SYF
|
+$88.5M |
| 3 |
Ross Stores
ROST
|
+$46.3M |
| 4 |
American Water Works
AWK
|
+$31.6M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$14.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.67% |
| 2 | Financials | 15.82% |
| 3 | Communication Services | 13.11% |
| 4 | Technology | 11.02% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Vanguard S&P 500 Growth ETF
VOOG
$25.9B
| $333K | ﹤0.01% |
12,408
-2,118
| -15% | -$55.8K |
|
502
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.07B
| $332K | ﹤0.01% |
3,047
-2,646
| -46% | -$285K |
|
503
Fortinet
FTNT
$119B
| $329K | ﹤0.01% |
21,380
+985
| +5% | +$16.2K |
|
504
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
| $329K | ﹤0.01% |
2,194
+8
| +0.4% | +$1.18K |
|
505
Takeda Pharmaceutical
TAK
$54.6B
| $328K | ﹤0.01% |
18,511
-41,176
| -69% | -$749K |
|
506
Expeditors International
EXPD
$22B
| $322K | ﹤0.01% |
4,250
-634
| -13% | -$47.9K |
|
507
Cincinnati Financial
CINF
$27.3B
| $321K | ﹤0.01% |
3,101
-8,356
| -73% | -$802K |
|
508
Morgan Stanley
MS
$331B
| $321K | ﹤0.01% |
7,333
-180
| -2% | -$8.03K |
|
509
Artisan Partners
APAM
$2.79B
| $318K | ﹤0.01% |
+11,539
| New | +$307K |
|
510
TC Energy
TRP
$70.2B
| $317K | ﹤0.01% |
6,403
+53
| +0.8% | +$2.54K |
|
511
Henry Schein
HSIC
$9.77B
| $316K | ﹤0.01% |
4,515
-925
| -17% | -$61.2K |
|
512
Cognizant
CTSH
$24.9B
| $314K | ﹤0.01% |
4,951
+668
| +16% | +$43.8K |
|
513
Truist Financial
TFC
$63.3B
| $313K | ﹤0.01% |
6,370
-3,538
| -36% | -$173K |
|
514
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.83B
| $308K | ﹤0.01% |
9,300
+3,826
| +70% | +$126K |
|
515
T. Rowe Price
TROW
$23.9B
| $308K | ﹤0.01% |
2,799
+260
| +10% | +$27.4K |
|
|
NXDT
516
NexPoint Diversified Real Estate Trust
NXDT
$234M
| $307K | ﹤0.01% |
16,236
+6,827
| +73% | +$136K |
|
517
State Street SPDR S&P Biotech ETF
XBI
$9.95B
| $306K | ﹤0.01% |
+3,492
| New | +$298K |
|
518
Teladoc Health
TDOC
$1.22B
| $304K | ﹤0.01% |
4,579
+751
| +20% | +$43.8K |
|
519
Northrop Grumman
NOC
$77.1B
| $300K | ﹤0.01% |
929
-403
| -30% | -$120K |
|
|
PBFX
520
DELISTED
PBF LOGISTICS LP
PBFX
| $294K | ﹤0.01% |
13,900
+4,750
| +52% | +$98.3K |
|
521
Ionis Pharmaceuticals
IONS
$8.6B
| $292K | ﹤0.01% |
4,543
-3,034
| -40% | -$214K |
|
522
Usana Health Sciences
USNA
$408M
| $291K | ﹤0.01% |
3,660
| – | – |
|
|
ETRN
523
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $290K | ﹤0.01% |
14,717
+50
| +0.3% | +$1.04K |
|
524
Akamai
AKAM
$16.7B
| $282K | ﹤0.01% |
3,514
-1,499
| -30% | -$116K |
|
525
Sarepta Therapeutics
SRPT
$1.57B
| $282K | ﹤0.01% |
1,857
-11
| -0.6% | -$1.34K |
|
Similar funds
Rockefeller Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Rockefeller Capital Management held 2,144 positions worth $7.17B, up 2.2% from $7.02B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Rockefeller Capital Management's Q2 2019 filing shows 214 new, 421 increased, 861 reduced and 501 closed positions. Its largest new stake was ForeScout Technologies, Inc. Common Stock: 198,862 shares worth $6.73M. The largest sale was Apple, an estimated $147M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Financials and Communication Services.
- Rockefeller Capital Management's largest Q2 2019 buy was ForeScout Technologies, Inc. Common Stock: 198,862 shares worth $6.73M.
- Rockefeller Capital Management added most to Lamb Weston in Q2 2019, an estimated $73.2M increase.
- Rockefeller Capital Management's biggest Q2 2019 reduction was Apple, cutting an estimated $147M.
- Rockefeller Capital Management fully exited TPI Composites in Q2 2019, selling an estimated $1.66M.
- Rockefeller Capital Management's ten largest holdings make up 31% of its $7.17B portfolio in Q2 2019.
- Rockefeller Capital Management opened 214 new positions and closed 501 in Q2 2019.
- Rockefeller Capital Management's portfolio value rose 2.2% quarter-over-quarter to $7.17B.
Based on Rockefeller Capital Management's 13F filing for Q2 2019, filed 9 Aug 2019.